Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

医学 内科学 DLCO公司 荟萃分析 子群分析 科克伦图书馆 安慰剂 不利影响 特发性肺纤维化 肺功能测试 随机对照试验 中医药 肺功能 肺 扩散能力 病理 替代医学
作者
Kun Ji,MA Jian-ling,WANG Liangmin,Niuniu Li,Shangjuan Dong,Shi Li-qing
出处
期刊:Evidence-based Complementary and Alternative Medicine [Hindawi Publishing Corporation]
卷期号:2020: 1-11 被引量:15
标识
DOI:10.1155/2020/1752387
摘要

To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis.Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM.A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = −0.51, 95% CI −0.70 to −0.22, p < 0.001). Subgroup analysis of different study durations (3 months, ≥ 6 months) and comparison models (TCM vs. WM, TCM + WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27–1.60, p=0.352). There was no obvious publication bias, and the pooled results were stable according to sensitivity analysis.To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
西西红柿的应助被once采纳,获得10
刚刚
JamesPei的应助被稳重的tutu采纳,获得10
刚刚
cc发布了新的文献求助10
刚刚
天天快乐的应助被优美的葶采纳,获得30
刚刚
温书禾完成签到 ,获得积分10
1秒前
李不理哩完成签到,获得积分10
2秒前
2秒前
坦率灵槐的应助被坚持坚持采纳,获得10
3秒前
sasa完成签到,获得积分10
3秒前
汉堡包的应助被小乐子采纳,获得10
4秒前
4秒前
4秒前
5秒前
6秒前
yysmile发布了新的文献求助20
7秒前
8秒前
8秒前
刘刘完成签到,获得积分10
9秒前
明朗完成签到 ,获得积分10
9秒前
稳重的tutu发布了新的文献求助10
9秒前
10秒前
12秒前
科研通AI6.4的应助被零度火采纳,获得10
12秒前
a_xin完成签到,获得积分10
12秒前
TOM完成签到,获得积分10
12秒前
Christina发布了新的文献求助50
13秒前
13秒前
14秒前
ZB完成签到 ,获得积分10
14秒前
suhc138发布了新的文献求助10
14秒前
NexusExplorer的应助被yangbiupa采纳,获得10
15秒前
科研通AI6.4的应助被Amber采纳,获得10
16秒前
肖兔子哇完成签到 ,获得积分10
16秒前
SciGPT的应助被Vater采纳,获得10
16秒前
鼻揩了转去的应助被慧慧采纳,获得10
17秒前
莫里亚蒂完成签到,获得积分10
17秒前
狂的没边完成签到,获得积分10
18秒前
18秒前
闪闪映天发布了新的文献求助10
19秒前
小蘑菇的应助被伞漆贝采纳,获得10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Exploring Mental Health in Education 600
Stochastic Models in Operations Research,Vol. 2 600
Organizational Behavior 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8048754
求助须知:如何正确求助?哪些是违规求助? 9478253
关于积分的说明 21292229
捐赠科研通 7617014
什么是DOI,文献DOI怎么找? 3392730
关于科研通互助平台的介绍 2524030
邀请新用户注册赠送积分活动 2430837